RPS6KB1 and cancer: Evidence has shown that miR-200b could target fascin actin-bundling protein 1 (FSCN1), and p70S6K1 and these two target genes (FSCN1 and p70S6K1) are involved in the chemoresistance of cancers (51, 52).